Addex Therapeutics Ltd Equity
Addex Therapeutics Ltd (ADXN) had Equity of CHF 7.21 million as of 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Notes
ifrs-full:Equity · last filed 2025-09-30
- 2025-06-30: Equity 7.21M CHF.
- 2025-03-31: Equity 8.30M CHF.
- 2024-12-31: Equity 9.68M CHF.
- 2024-06-30: Equity 12.65M CHF.
| Period end | Equity |
|---|---|
| 2025-06-30 | 7.21M CHF 6-K · filed 2025-09-30 |
| 2025-03-31 | 8.30M CHF 6-K · filed 2025-09-30 |
| 2024-12-31 | 9.68M CHF 6-K · filed 2025-09-30 |
| 2024-06-30 | 12.65M CHF 6-K · filed 2025-09-30 |
| 2024-03-31 | -1.37M CHF 6-K · filed 2025-09-30 |
| 2023-12-31 | 1.15M CHF 6-K · filed 2025-09-30 |
| 2023-06-30 | 6.13M CHF 6-K/A · filed 2023-12-21 |
| 2023-03-31 | 4.07M CHF 6-K/A · filed 2023-12-21 |
| 2022-12-31 | 4.91M CHF 20-F · filed 2025-05-15 |
| 2022-06-30 | 6.86M CHF 6-K/A · filed 2023-12-21 |
| 2022-03-31 | 12.96M CHF 6-K/A · filed 2023-12-21 |
| 2021-12-31 | 16.93M CHF 20-F · filed 2025-05-15 |
| 2021-06-30 | 16.42M CHF 6-K/A · filed 2022-09-14 |
| 2021-03-31 | 20.70M CHF 6-K/A · filed 2022-09-14 |
| 2020-12-31 | 14.61M CHF 20-F · filed 2024-04-18 |
| 2019-12-31 | 25.52M CHF 20-F · filed 2023-03-30 |
| 2018-12-31 | 39.24M CHF 20-F · filed 2022-03-10 |
| 2017-12-31 | 1.34M CHF 20-F · filed 2021-03-11 |
| 2016-12-31 | 218.59K CHF 20-F · filed 2020-04-27 |